Abecma for car-t
Ended Awarded Last action
- Contract number
- 36C24926N0219
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $338,933
Award facts
- Contract value 100% obligated
- $338,932.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Bristol-Myers Squibb Company, a global biopharmaceutical company, for the delivery of ABECMA, a chimeric antigen receptor (CAR) T-cell therapy. The $338,932.84 firm fixed-price delivery order contract was awarded on October 9, 2025 by the Department of Veterans Affairs (VA) and has an ultimate completion date of January 8, 2026. The contract is funded through the VA's Veterans Integrated Service Network 9 and is not designated as a set-aside.
The contract is part of Bristol-Myers Squibb's broader Federal Supply Schedule (FSS) contract with the VA, valued at $12,278,876,570.00 and running through April 30, 2029. This multiple-award FSS contract covers a range of pharmaceutical and drug products, with a focus on oncology and immunotherapy treatments. The contract enables the VA to efficiently procure advanced medical therapies like ABECMA to support the agency's mission of providing high-quality care to eligible veterans.
Quick answers
Who was awarded contract 36C24926N0219?
36C24926N0219 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 9, 2025.
How much is contract 36C24926N0219 worth?
The government has obligated $338,933 on 36C24926N0219.
Is contract 36C24926N0219 an order under another contract?
Yes. 36C24926N0219 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926N0219 competed?
The extent of competition for 36C24926N0219 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award